Literature DB >> 35484237

Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review.

Elena Dragioti1, Joaquim Radua2,3,4, Marco Solmi2,5,6,7, Celso Arango8,9,10, Dominic Oliver2, Samuele Cortese7,11,12,13,14, Peter B Jones15,16, Jae Il Shin17,18, Christoph U Correll19,20,21,22, Paolo Fusar-Poli23,24,25.   

Abstract

Numerous risk factors for mental disorders have been identified. However, we do not know how many disorders we could prevent and to what extent by modifying these risk factors. This study quantifies the Population Attributable Fraction (PAF) of potentially modifiable risk factors for mental disorders. We conducted a PRISMA 2020-compliant (Protocol: https://osf.io/hk2ag ) meta-umbrella systematic review (Web of Science/PubMed/Cochrane Central Register of Reviews/Ovid/PsycINFO, until 05/12/2021) of umbrella reviews reporting associations between potentially modifiable risk factors and ICD/DSM mental disorders, restricted to highly convincing (class I) and convincing (class II) evidence from prospective cohorts. The primary outcome was the global meta-analytical PAF, complemented by sensitivity analyses across different settings, the meta-analytical Generalised Impact Fraction (GIF), and study quality assessment (AMSTAR). Seven umbrella reviews (including 295 meta-analyses and 547 associations) identified 28 class I-II risk associations (23 risk factors; AMSTAR: 45.0% high-, 35.0% medium-, 20.0% low quality). The largest global PAFs not confounded by indication were 37.84% (95% CI = 26.77-48.40%) for childhood adversities and schizophrenia spectrum disorders, 24.76% (95% CI = 13.98-36.49%) for tobacco smoking and opioid use disorders, 17.88% (95% CI = not available) for job strain and depression, 14.60% (95% CI = 9.46-20.52%) for insufficient physical activity and Alzheimer's disease, 13.40% (95% CI = 7.75-20.15%) for childhood sexual abuse and depressive disorders, 12.37% (95% CI = 5.37-25.34%) for clinical high-risk state for psychosis and any non-organic psychotic disorders, 10.00% (95% CI = 5.62-15.95%) for three metabolic factors and depression, 9.73% (95% CI = 4.50-17.30%) for cannabis use and schizophrenia spectrum disorders, and 9.30% (95% CI = 7.36-11.38%) for maternal pre-pregnancy obesity and ADHD. The GIFs confirmed the preventive capacity for these factors. Addressing several potentially modifiable risk factors, particularly childhood adversities, can reduce the global population-level incidence of mental disorders.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35484237     DOI: 10.1038/s41380-022-01586-8

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  64 in total

1.  Natural history of syphilis and levels of prevention.

Authors:  E G CLARK
Journal:  Br J Vener Dis       Date:  1954-12

Review 2.  Preventive strategies for mental health.

Authors:  Celso Arango; Covadonga M Díaz-Caneja; Patrick D McGorry; Judith Rapoport; Iris E Sommer; Jacob A Vorstman; David McDaid; Oscar Marín; Elena Serrano-Drozdowskyj; Robert Freedman; William Carpenter
Journal:  Lancet Psychiatry       Date:  2018-05-15       Impact factor: 27.083

Review 3.  Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis.

Authors:  Gonzalo Salazar de Pablo; Andrea De Micheli; Dorien H Nieman; Christoph U Correll; Lars Vedel Kessing; Andrea Pfennig; Andreas Bechdolf; Stefan Borgwardt; Celso Arango; Therese van Amelsvoort; Eduard Vieta; Marco Solmi; Dominic Oliver; Ana Catalan; Valeria Verdino; Lucia Di Maggio; Ilaria Bonoldi; Julio Vaquerizo-Serrano; Ottone Baccaredda Boy; Umberto Provenzani; Francesca Ruzzi; Federica Calorio; Guido Nosari; Benedetto Di Marco; Irene Famularo; Silvia Molteni; Eleonora Filosi; Martina Mensi; Umberto Balottin; Pierluigi Politi; Jae Il Shin; Paolo Fusar-Poli
Journal:  Eur Neuropsychopharmacol       Date:  2020-11-06       Impact factor: 4.600

Review 4.  European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP).

Authors:  Paolo Fusar-Poli; Michael Bauer; Stefan Borgwardt; Andreas Bechdolf; Christoph U Correll; Kim Q Do; Katharina Domschke; Silvana Galderisi; Lars Vedel Kessing; Nikolaos Koutsouleris; Marie-Odile Krebs; Belinda Lennox; Philip McGuire; Andreas Meyer-Lindenberg; Mark J Millan; Dorien Nieman; Andrea Pfennig; Michael Sand; Allan Whenert; Therese van Amelsvoort; Celso Arango
Journal:  Eur Neuropsychopharmacol       Date:  2019-10-09       Impact factor: 4.600

5.  The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Authors:  Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2017-01       Impact factor: 9.306

6.  Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.

Authors:  Paolo Fusar-Poli; Gonzalo Salazar de Pablo; Christoph U Correll; Andreas Meyer-Lindenberg; Mark J Millan; Stefan Borgwardt; Silvana Galderisi; Andreas Bechdolf; Andrea Pfennig; Lars Vedel Kessing; Therese van Amelsvoort; Dorien H Nieman; Katharina Domschke; Marie-Odile Krebs; Nikolaos Koutsouleris; Philip McGuire; Kim Q Do; Celso Arango
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

Review 7.  Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention.

Authors:  Ana Catalan; Gonzalo Salazar de Pablo; Julio Vaquerizo Serrano; Pierluca Mosillo; Helen Baldwin; Aranzazu Fernández-Rivas; Carmen Moreno; Celso Arango; Christoph U Correll; Ilaria Bonoldi; Paolo Fusar-Poli
Journal:  J Child Psychol Psychiatry       Date:  2020-09-14       Impact factor: 8.982

Review 8.  Clinical Validity of DSM-5 Attenuated Psychosis Syndrome: Advances in Diagnosis, Prognosis, and Treatment.

Authors:  Gonzalo Salazar de Pablo; Ana Catalan; Paolo Fusar-Poli
Journal:  JAMA Psychiatry       Date:  2020-03-01       Impact factor: 21.596

Review 9.  From Basic Science to Clinical Application of Polygenic Risk Scores: A Primer.

Authors:  Naomi R Wray; Tian Lin; Jehannine Austin; John J McGrath; Ian B Hickie; Graham K Murray; Peter M Visscher
Journal:  JAMA Psychiatry       Date:  2021-01-01       Impact factor: 21.596

10.  Preventive psychiatry: a blueprint for improving the mental health of young people.

Authors:  Paolo Fusar-Poli; Christoph U Correll; Celso Arango; Michael Berk; Vikram Patel; John P A Ioannidis
Journal:  World Psychiatry       Date:  2021-06       Impact factor: 79.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.